Skip to main content
. 2016 Jul 13;65(1):120–128. doi: 10.1007/s12026-016-8821-y

Table 1.

Criteria for the diagnosis of ASIA

Major criteria
• Exposure to an external stimulus (infection, vaccine, silicone, adjuvant) prior to clinical manifestations
• The appearance of ‘typical’ clinical manifestations:
 - Myalgia, Myositis or muscle weakness
 - Arthralgia and/or arthritis
 - Chronic fatigue, un-refreshing sleep or sleep disturbances
 - Neurological manifestations (especially associated with demyelination)
 - Cognitive impairment, memory loss
 - Pyrexia, dry mouth
• Removal of inciting agent induces improvement
• Typical biopsy of involved organs
Minor criteria
• The appearance of autoantibodies or antibodies directed at the suspected adjuvant
• Other clinical manifestations (i.e. irritable bowel syndrome)
• Specific HLA (i.e. HLA DRB1, HLA DQB1)
• Evolvement of an autoimmune disease (i.e. multiple sclerosis, systemic sclerosis)

ASIA autoimmune/inflammatory syndrome induced by adjuvants